Taiko Pharmaceutical Co.,Ltd. (4574.T)
JPY 273.0
(-1.44%)
JPY 273.0
(-1.44%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 3.8 Billion JPY | -20.2% |
| 2021 | 4.77 Billion JPY | 4929.98% |
| 2020 | 94.89 Million JPY | 21.65% |
| 2019 | 78 Million JPY | 40.77% |
| 2018 | 55.41 Million JPY | 90.37% |
| 2017 | 29.1 Million JPY | -13.58% |
| 2016 | 33.67 Million JPY | -19.82% |
| 2015 | 42 Million JPY | -98.06% |
| 2014 | 2.16 Billion JPY | 5156.33% |
| 2013 | 41.1 Million JPY | 46.21% |
| 2012 | 28.11 Million JPY | -28.61% |
| 2011 | 39.37 Million JPY | -27.67% |
| 2010 | 54.44 Million JPY | -13.01% |
| 2009 | 62.58 Million JPY | 62.17% |
| 2008 | 38.59 Million JPY | 0.0% |
| 2007 | - JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 3.16 Billion JPY | -7.58% |
| 2023 Q1 | 3.42 Billion JPY | -9.98% |
| 2023 Q3 | 2.97 Billion JPY | -6.0% |
| 2022 Q1 | 4.41 Billion JPY | -7.42% |
| 2022 FY | 3.8 Billion JPY | -20.2% |
| 2022 Q4 | 3.8 Billion JPY | -3.55% |
| 2022 Q3 | 3.94 Billion JPY | -6.18% |
| 2022 Q2 | 4.2 Billion JPY | -4.75% |
| 2021 Q2 | 3.99 Billion JPY | 299.9% |
| 2021 Q4 | 4.77 Billion JPY | -1.36% |
| 2021 Q3 | 4.83 Billion JPY | 21.01% |
| 2021 FY | 4.77 Billion JPY | 4929.98% |
| 2021 Q1 | 1 Billion JPY | 0.0% |
| 2020 Q2 | - JPY | -100.0% |
| 2020 FY | 94.89 Million JPY | 21.65% |
| 2020 Q1 | 78 Million JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2019 FY | 78 Million JPY | 40.77% |
| 2019 Q1 | 55.41 Million JPY | 0.0% |
| 2019 Q2 | - JPY | -100.0% |
| 2019 Q4 | - JPY | 0.0% |
| 2019 Q3 | - JPY | 0.0% |
| 2018 FY | 55.41 Million JPY | 90.37% |
| 2018 Q2 | - JPY | -100.0% |
| 2018 Q1 | 29.1 Million JPY | 0.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 Q4 | - JPY | 0.0% |
| 2017 Q3 | - JPY | 0.0% |
| 2017 FY | 29.1 Million JPY | -13.58% |
| 2017 Q4 | - JPY | 0.0% |
| 2017 Q2 | - JPY | -100.0% |
| 2017 Q1 | 33.67 Million JPY | 0.0% |
| 2016 Q4 | - JPY | 0.0% |
| 2016 Q2 | - JPY | -100.0% |
| 2016 Q3 | - JPY | 0.0% |
| 2016 FY | 33.67 Million JPY | -19.82% |
| 2016 Q1 | 42 Million JPY | -95.87% |
| 2015 Q1 | 2.16 Billion JPY | 0.0% |
| 2015 Q4 | 1.01 Billion JPY | 0.09% |
| 2015 FY | 42 Million JPY | -98.06% |
| 2015 Q2 | - JPY | -100.0% |
| 2015 Q3 | 1.01 Billion JPY | 0.0% |
| 2014 Q2 | - JPY | -100.0% |
| 2014 FY | 2.16 Billion JPY | 5156.33% |
| 2014 Q3 | - JPY | 0.0% |
| 2014 Q1 | 41.1 Million JPY | 0.0% |
| 2014 Q4 | - JPY | 0.0% |
| 2013 Q4 | - JPY | 0.0% |
| 2013 Q1 | 28.11 Million JPY | 0.0% |
| 2013 Q2 | - JPY | -100.0% |
| 2013 FY | 41.1 Million JPY | 46.21% |
| 2013 Q3 | - JPY | 0.0% |
| 2012 FY | 28.11 Million JPY | -28.61% |
| 2012 Q4 | - JPY | 0.0% |
| 2012 Q3 | - JPY | 0.0% |
| 2012 Q2 | - JPY | -100.0% |
| 2012 Q1 | 39.37 Million JPY | 0.0% |
| 2011 Q3 | - JPY | 0.0% |
| 2011 Q4 | - JPY | 0.0% |
| 2011 FY | 39.37 Million JPY | -27.67% |
| 2011 Q2 | - JPY | -100.0% |
| 2011 Q1 | 54.44 Million JPY | 0.0% |
| 2010 FY | 54.44 Million JPY | -13.01% |
| 2010 Q1 | 62.58 Million JPY | 0.0% |
| 2010 Q2 | - JPY | -100.0% |
| 2010 Q4 | - JPY | 0.0% |
| 2010 Q3 | - JPY | 0.0% |
| 2009 Q2 | - JPY | -100.0% |
| 2009 Q3 | - JPY | 0.0% |
| 2009 Q4 | - JPY | 0.0% |
| 2009 Q1 | 38.59 Million JPY | 0.0% |
| 2009 FY | 62.58 Million JPY | 62.17% |
| 2008 FY | 38.59 Million JPY | 0.0% |
| 2007 FY | - JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | 77.45% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.921% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 99.091% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | 67.22% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -3688.956% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -32.625% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | 1.065% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 98.158% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -796.235% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -81.381% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -932.249% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | 70.06% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 77.569% |
| Tsumura & Co. | 79.69 Billion JPY | 95.22% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -120.556% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -1461.066% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 98.118% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 86.842% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 91.996% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | 81.815% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | 56.314% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -6248.333% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -823.394% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | 59.842% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 95.405% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -317.196% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 87.406% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -34.818% |